NMBAs are classified into two main types: depolarizing and non-depolarizing agents, based on their mechanism of action.
Depolarizing Neuromuscular Blocking Agents
Depolarizing NMBAs, such as succinylcholine, act by mimicking acetylcholine. When administered, succinylcholine binds to the ACh receptors on the postsynaptic membrane, causing a prolonged depolarization. This initially leads to muscle fasciculations (visible muscle twitches) followed by sustained flaccid paralysis. The depolarized membrane remains refractory to subsequent stimulation, which prevents muscle contraction. One of the key features of succinylcholine is its rapid onset of action, typically producing paralysis within 1 minute, making it ideal for emergency situations like rapid sequence intubation. Its duration of action is short, lasting approximately 5 to 10 minutes, as it is rapidly metabolized by plasma pseudocholinesterase. However, conditions such as pseudocholinesterase deficiency can prolong its effects, necessitating extended postoperative mechanical ventilation.
Non-Depolarizing Neuromuscular Blocking Agents
Non-depolarizing NMBAs, including rocuronium, vecuronium, atracurium, cisatracurium, and pancuronium, act as competitive antagonists to acetylcholine. They bind to the nicotinic ACh receptors on the postsynaptic membrane without activating them, effectively blocking ACh from binding and preventing depolarization. This blockade results in muscle paralysis without the initial fasciculations seen with depolarizing agents. Non-depolarizing agents are further subdivided into two groups based on their chemical structure: steroidal agents (e.g., rocuronium, vecuronium, pancuronium) and benzylisoquinolinium agents (e.g., atracurium, cisatracurium, mivacurium). The duration of action and metabolism of these agents vary, with some undergoing hepatic or renal elimination and others, like cisatracurium, being metabolized via Hofmann elimination, making them ideal for patients with organ dysfunction.
